A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 330 participants.
Also called NCT07922330
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 330 participants
- Sponsor
- Registry
-
NCT07922330
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China, India
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07922330. Randomized; triple masking; primary purpose treatment. Start 2027-01-04 (anticipated); primary completion 2028-09-15 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
- Acronym
- SELENE-Asia
- Condition
- Obesity
- Condition
- Overweight
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- AZD6234
- Intervention (Drug)
- Placebo
- Lead sponsor
- AstraZeneca
Record details
- Record id
cardio:ct-nct07922330- Content hash
ac33ee732d87209e7cb1719209274dc28b0b36d1ea25e927249a4c60c60e69e4